<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0406500" disease_type="Disease or Syndrome" abbrv="">Lipodermatosclerosis</z:e> (LDS) is a clinical condition characterized by the appearance of hardened, painful, and hyperchromic plaques on the legs </plain></SENT>
<SENT sid="1" pm="."><plain>We describe three patients with diffuse <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> (DCTD) who developed this clinical condition </plain></SENT>
<SENT sid="2" pm="."><plain>The first one was a <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> patient with <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e>; the second patient had a superposition of DCTD (<z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e>, <z:e sem="disease" ids="C1527383" disease_type="Disease or Syndrome" abbrv="">morphea</z:e>); and the last one had been diagnosed with CREST 10 years earlier but had more recently developed primary <z:hpo ids='HP_0002613'>biliary cirrhosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Although its etiopathogenesis is unknown, LDS has been frequently seen in association with <z:hpo ids='HP_0005293'>venous insufficiency</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Its recognition by professionals who deal with DCTD is very relevant since it is characterized by thickening of the skin, similar to <z:hpo ids='HP_0100324'>scleroderma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Its identification can avoid the inadvertent use of medications such as <z:chebi fb="0" ids="50868,7959">penicillamine</z:chebi> and <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi>, which have potentially serious side effects </plain></SENT>
</text></document>